Evogene Ltd Share Price Today: Live Updates & Key Insights

Evogene Ltd share price today is $0.5425, up -0.04%. The stock opened at $0.53725 against the previous close of $0.5427, with an intraday high of $0.54335 and low of $0.5364.

Evogene Ltd Share Price Chart

Evogene Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Evogene Ltd Share Price Performance

$0.5425 -0.0004(-0.04%) EVGN at 27 Jul 2026 02:55 PM Biotechnology
Lowest Today 0.5364
Highest Today 0.54335
Today’s Open 0.53725
Prev. Close 0.5427
52 Week High 1.50
52 Week Low 0.37
Day’s Range: Low 0.5364 High 0.54335
52-Week Range: Low 0.37 High 1.50
1 day return -
1 Week return -1.19
1 month return +36.45
3 month return -30.33
6 month return -49.39
1 year return -57.08
3 year return -50.33
5 year return -81.43
10 year return -

Evogene Ltd Institutional Holdings

Armistice Capital, LLC 4.38

Jane Street Group LLC 0.18

XTX Topco Ltd 0.12

TWO SIGMA SECURITIES, LLC 0.12

Daytona Street Capital LLC 0.09

BNP Paribas Arbitrage, SA 0.09

P & S Renditefonds T 0.08

UBS Group AG 0.06

Morgan Stanley - Brokerage Accounts 0.04

Fidelity Nasdaq Composite Index 0.03

Federation des caisses Desjardins du Quebec 0.00

Steward Partners Investment Advisory, LLC 0.00

Tradewinds Capital Management, LLC 0.00

Advisor Group Holdings, Inc. 0.00

SBI Securities Co Ltd 0.00

SHP Wealth Management 0.00

Royal Bank of Canada 0.00

Acadian Asset Management LLC 0.00

Altshuler Shaham Ltd 0.00

Bank of America Corp 0.00

Citadel Advisors Llc 0.00

Evogene Ltd Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Evogene Ltd Fundamentals

Market Cap 6.57 M

PB Ratio 6.176

PE Ratio 0.0

Enterprise Value -4.28 M

Total Assets 20.05 M

Volume 30935

Evogene Ltd Company Financials

Annual Revenue FY23:5722000 5.7M, FY22:1675000 1.7M, FY21:930000 0.9M, FY20:1040000 1.0M, FY19:753000 0.8M

Annual Profit FY23:4064000 4.1M, FY22:766000 0.8M, FY21:163000 0.2M, FY20:466000 0.5M, FY19:419000 0.4M

Annual Net worth FY23:-20276000 -20.3M, FY22:-29844000 -29.8M, FY21:-30445000 -30.4M, FY20:-26206000 -26.2M, FY19:-19115000 -19.1M

Quarterly Revenue Q1/2026:334000 0.3M, Q3/2025:312000 0.3M, Q2/2025:884000 0.9M, Q1/2025:2444000 2.4M, Q3/2024:1796000 1.8M

Quarterly Profit Q1/2026:204000 0.2M, Q3/2025:-126000 -0.1M, Q2/2025:458000 0.5M, Q1/2025:251000 0.3M, Q3/2024:715000 0.7M

Quarterly Net worth Q1/2026:-5870000 -5.9M, Q3/2025:3874000 3.9M, Q2/2025:-4462000 -4.5M, Q1/2025:-2587000 -2.6M, Q3/2024:-7630000 -7.6M

About Evogene Ltd & investment objective

Company Information Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.

Organisation Biotechnology

Employees 52

Industry Biotechnology

CEO Mr. Ofer Haviv CPA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Evogene Ltd FAQs

What is the share price of Evogene Ltd today?

The current share price of Evogene Ltd is $0.5425.

Can I buy Evogene Ltd shares in India?

Yes, Indian investors can buy Evogene Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Evogene Ltd shares in India?

You can easily invest in Evogene Ltd shares from India by:

Can I buy fractional shares of Evogene Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Evogene Ltd?

Evogene Ltd has a market cap of $6.57 M.

In which sector does Evogene Ltd belong?

Evogene Ltd operates in the Biotechnology sector.

What documents are required to invest in Evogene Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Evogene Ltd?

The PE ratio of Evogene Ltd is N/A and the PB ratio is 6.18.